Central vs nephrogenic diabetes insipidus: the desmopressin test and beyond

The deciding finding: response to desmopressin

Both types leave the patient passing large amounts of very dilute urine. MSD Manuals describes urine specific gravity below 1.005 and osmolality under 200 mOsm/kg in untreated central diabetes insipidus. The difference shows up when synthetic vasopressin is given during testing: one type responds and the other largely does not.

MSD Manuals reports that in central diabetes insipidus urine osmolality rises by 50% or more after vasopressin when the hormone deficiency is complete, and by 15 to 50% when it is partial. In nephrogenic diabetes insipidus the rise is minimal, typically under 50 mOsm/kg. The logic is simple: replacing a missing hormone works, but adding more hormone to kidneys that ignore it does not.

Causes that hint at the type before any test

Central diabetes insipidus follows damage to the hypothalamus or pituitary. NIDDK lists surgery, tumors, infection, head injury and autoimmune disease, and MSD Manuals highlights pituitary surgery and basal skull fractures. On exams, a client after transsphenoidal surgery or a head injury who suddenly passes huge volumes of pale urine is the classic central picture.

Nephrogenic diabetes insipidus is a kidney problem. Lithium is the best-known drug cause, and MSD Manuals adds demeclocycline and amphotericin B among others. Low potassium, high calcium, urinary tract blockage and inherited receptor mutations also cause it, according to NIDDK. A client on long-term lithium with new polyuria should make the nurse think nephrogenic first.

What looks the same in both

Thirst, polyuria, nocturia, dilute urine and the risk of dehydration with high serum sodium appear in both types, especially when the patient cannot drink freely, such as after surgery or with confusion. The water deprivation test itself, which NIDDK describes as stopping fluids for several hours while weight, urine and blood are tracked, shows that urine stays dilute in both.

That is why the deprivation phase alone cannot separate them; the vasopressin step does. During testing the nurse weighs the client, measures every void, and reports signs of excessive dehydration promptly, because the client keeps losing water. Comparing diabetes insipidus with SIADH, the opposite water problem, is covered on the linked page.

Nursing care that differs between them

Central diabetes insipidus is treated with desmopressin, which replaces the missing hormone. The nursing watch point is the opposite problem: MSD Manuals warns that too much can cause fluid retention and low plasma osmolality, so monitor sodium, weight, headache and confusion, and teach clients to drink to thirst rather than forcing fluids.

Nephrogenic diabetes insipidus does not respond to desmopressin, so care targets the cause and the urine volume. NIDDK describes switching medicines and correcting calcium or potassium. MSD Manuals adds adequate free water, a low-salt, low-protein diet to cut solute load, and thiazide diuretics, which reduce urine output in this condition even though that seems backward.

Hypothetical practice scenario

Hypothetical scenario, not a real exam item: a client with bipolar disorder who has taken lithium for years reports constant thirst and passing large amounts of pale urine. Urine osmolality barely changes after desmopressin is given. Which finding should the nurse expect the team to focus on next: the lithium therapy, a recent head injury, or fluid restriction?

The lithium therapy is the key, because the minimal desmopressin response and lithium use both point to nephrogenic diabetes insipidus. A head injury is the tempting distractor because it is the textbook trigger for diabetes insipidus, but it causes the central type. Fluid restriction is unsafe here; the client needs access to water.

Sources and further reading

MSD Manual Professional Version: Central Diabetes Insipidus. Causes including pituitary surgery and skull fractures, dilute urine values, urine osmolality rise after vasopressin, desmopressin treatment and overdose risk of fluid retention.

MSD Manual Professional Version: Nephrogenic Diabetes Insipidus. Inherited and drug causes including lithium, minimal response to vasopressin, free water, low-salt low-protein diet and thiazide treatment.

NIDDK: Diabetes Insipidus. Definitions of central and nephrogenic types, causes including low potassium and high calcium, water deprivation test procedure, desmopressin for central and thiazides for nephrogenic.